ArticleInternational journal of molecular sciences2017

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.

Lisa Pleyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.